Anti-pandemic: Search for New Therapeutics from the Natural Kingdom and Laboratory
A special issue of Medicines (ISSN 2305-6320). This special issue belongs to the section "New Drugs Exploration and Development".
Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 587
Special Issue Editor
Interests: informatics; information network; pharmacy; biological pharmacy; basic medicine; general pharmacology; boundary medicine; laboratory medicine; dentistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues:
The new coronavirus (COVID-19) infection has seriously affected our daily life. At present, there is no specific drug for this virus, and vaccine production is not yet ready. Therefore, existing antiviral drugs and traditional Chinese medicines are being tested for their antiviral potential.
This Special Issue calls for reviews and original articles on the current status of specific drug development, the possibly efficacy of existing and newly synthesized antiviral drugs, and search of nonspecific antiviral substances from natural resources.
Prof. Dr. Hiroshi Sakagami
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
